InvestorsHub Logo
Followers 73
Posts 3609
Boards Moderated 0
Alias Born 03/23/2013

Re: Laurent Maldague post# 358321

Thursday, 10/28/2021 6:12:55 PM

Thursday, October 28, 2021 6:12:55 PM

Post# of 426536
Cardiolink9 data proved its efficacy as a Covid-19 therapeutic. V is amazing. No doubt we'll see similar results with P2.

What we are probably witnessing is $ being stuffed in a certain researcher's pocket to question the placebo, delay top line data and stall on P3... all to allow a catalyst free period when doubt would rule and the share price would slide (job well done).

What the company needs is a criminal investigation of a lot of people connected adversely to the company
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News